Search Results

Displaying Results 201-225 of 503 "'PFS'"

Feb 17, 2026, 07:00 ET Defense Metals Announces Pilot-Scale Flotation Test Program for Wicheeda Rare Earth Project

as detailed in the Company's 2025 Pre Feasibility Study ("PFS") (refer to Company News Release April 7th, 2025) prepared in accordance with National Instrument 43-101 Standards of Disclosure for Mineral Projects ("NI 43-101"). The PFS, showed the economic potential of the deposit, supporting

More news about: Defense Metals Corp.


Feb 17, 2026, 06:00 ET IDEAYA Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides a Business Update

topline PFS results," said Yujiro S. Hata, President and Chief Executive Officer, IDEAYA Biosciences.Selected Recent Developments and Upcoming MilestonesDarovasertib in Uveal Melanoma (UM)Topline results, including progression free survival (PFS) data,

More news about: IDEAYA Biosciences, Inc.


Feb 16, 2026, 08:30 ET Shallow High-Grade Cu-Au Results Continue at La Verde

open pit mine schedule, significantly reducing payback and positively impacting key financial metrics of Hot Chili's March 2025 Pre-Feasibility Study ("PFS"). Latest results include:DKD036 recorded 150 m grading 0.52% CuEq1 (0.37% Cu, 0.21 g/t Au) from 30 m depth

More news about: Hot Chili Limited


Feb 16, 2026, 06:45 ET Lilly's Retevmo (selpercatinib) delivers substantial event-free survival benefit as an adjuvant therapy in early-stage RET fusion-positive lung cancer

disease recurrence in the central nervous system (CNS) as assessed by investigator and BICR, progression-free survival on the next line of treatment (PFS2), positive predictive value (PPV) of RET tests from investigator-identified laboratories with respect to the Lilly-designated RET test,

More news about: Eli Lilly and Company


Feb 12, 2026, 19:00 ET Innovent Dosed First Participant in Phase 3 Clinical Study of IBI354 (Novel HER2 ADC) for First Line Treatment of HER2-positive Breast Cancer

pertuzumab, compared with the current standard-of-care, paclitaxel plus trastuzumab and pertuzumab (THP). The primary endpoint is progression-free survival (PFS).Previously, in a multicenter Phase 1/2 study in participants with advanced solid tumors, a total of 88 participants with HER2-positive breast

More news about: Innovent Biologics


Feb 11, 2026, 09:42 ET Polymetallic Explorers Gain Ground as Copper Deficit Reshapes Discovery Premiums

Studies. Assay results for 91 holes were prepared in mid-January for inclusion into the NI 43-101 Mineral Resource Estimate that will be used in the PFS, representing a substantial increase over the 39 holes considered in the 2025 El Cura maiden MRE.Amaroq (TSXV: AMRQ) (OTCQX: AMRQF) has

More news about: Equity Insider


Feb 11, 2026, 07:00 ET Mayfair Gold Presents the Initial Results from the 2025 Grade Control Drilling Program at the Fenn-Gib Project

confidence in the highest‑grade, early years of the Fenn‑Gib mine. While preliminary, they indicate potential for positive grade reconciliation, support the PFS early‑year assumptions, and are providing important data to advance project financing. Remaining assays are expected in Q1 2026."The Grade

More news about: Mayfair Gold Corp.


Feb 10, 2026, 17:31 ET PROTAC Market Shows Accelerated Growth During the Forecast Period (2025-2034) Amid Rising Targeted Therapy Demand | DelveInsight

the Phase III VERITAC-2 trial, which met its primary endpoint in the ESR1m population, showing a significant improvement in progression-free survival (PFS) compared to fulvestrant, exceeding the pre-specified target Hazard Ratio (HR) of 0.60. However, the trial did not reach statistical significance in

More news about: DelveInsight Business Research LLP


Feb 10, 2026, 09:17 ET What Americans Really Want in 2026: A Car for Gen Z, a Vacation for Millennials, Retirement Security for Gen X

on debt reduction. "Our survey findings highlight just how differently each generation is experiencing today's economy," says Pamela Ladd, CPA/PFS AICPA's Senior Manager of Personal Financial Planning. "While Gen Z's goals for 2026 are focused on major life milestones like buying a car or home,

More news about: AICPA


Feb 10, 2026, 07:01 ET 1911 Gold Delivers Positive PEA for True North Highlighting Robust Economics with Low Capital Intensity and High Returns

plan, in preparation for inclusion in the planned Pre-Feasibility Study ("PFS") mine planDrill test extensions of planned mining areas within the first years of the PEA to add additional resources for inclusion in the PFSRegain access and re-establish infrastructure to all of the

More news about: 1911 Gold Corporation


Feb 09, 2026, 09:07 ET New Study in JNCCN Unlocks Important Information About How to Treat Recurring Prostate Cancer

showed no visible disease on the scans (T0N0M0) had the most favorable PFS, and whole-pelvis radiotherapy (WPRT) had no significant benefit compared to prostate bed radiotherapy alone. However, WPRT did significantly improve PFS for patients with local, visible disease (TrN0M0). For patients with nodal

More news about: National Comprehensive Cancer Network


Feb 06, 2026, 04:00 ET Kelun-Biotech Announces Fourth Indication for Sacituzumab Tirumotecan (sac-TMT) Approved by NMPA in HR+/HER2- Breast Cancer

clinically meaningful increase in progression-free survival (PFS) as assessed by the Blinded Independent Central Review (BICR) compared to chemotherapy (8.3 vs. 4.1 months; hazard ratios (HR), 0.35; 95% CI: 0.26-0.48; p<0.0001). Consistent PFS benefits were observed across all pre-specified subgroups,

More news about: Kelun-biotech


Feb 05, 2026, 07:00 ET Mayfair Submits Fenn-Gib Gold Project Notice of Project Status

Canadian gold development stage company focused on advancing the 100% controlled Fenn-Gib Gold Project in the Timmins region of Northern Ontario. The PFS outlines the potential to develop Fenn-Gib into a new Canadian gold producer for initial development capital of C$450 million, with a base case payback

More news about: Mayfair Gold Corp.


Feb 05, 2026, 04:00 ET Signing of strategic technology supply and offtake agreement with Carester, US$20 million equity investment from the Industrial Development Corporation, and commencement of DFS for the Zandkopsdrift magnet rare earths and battery grade manganese project in South Africa

ZandkopsdriftIncludes 7-year offtake for MHREC, which will be processed at Carester's Lacq facility in FranceUpdated Prefeasibility Study ("PFS") on Zandkopsdrift project completed in 2025Expected to be lowest-cost producer of battery-grade manganese globally and

More news about: Frontier Rare Earths Limited


Feb 05, 2026, 04:00 ET Signing of strategic technology supply and offtake agreement with Carester, US$20 million equity investment from the Industrial Development Corporation, and commencement of DFS for the Zandkopsdrift magnet rare earths and battery grade manganese project in South Africa

ZandkopsdriftIncludes 7-year offtake for MHREC, which will be processed at Carester's Lacq facility in FranceUpdated Prefeasibility Study ("PFS") on Zandkopsdrift project completed in 2025Expected to be lowest-cost producer of battery-grade manganese globally and

More news about: Frontier Rare Earths Limited


Feb 04, 2026, 10:15 ET Finseca & IAQFP Announce Unification to Strengthen Financial Planning

the free, online, 24/7, QFP Verification Registry of Qualified Financial Planners:Personal Financial Specialist® (PFS)Certified Financial Planner (CFP®)Chartered Financial Consultant® (ChFC®)Master of Science

More news about: Finseca


Feb 04, 2026, 07:48 ET AbbVie Reports Full-Year and Fourth-Quarter 2025 Financial Results

based on results from the Phase 3 EPCORE FL-1 study in which Epkinly with R2 demonstrated significantly superior progression-free survival (PFS) and overall response (OR) rates compared to standard of care R2, with approximately three out of four patients achieving a complete response

More news about: AbbVie


Feb 02, 2026, 16:05 ET ADC Therapeutics Makes Grants to New Employees Under Inducement Plan

timing, publication and outcome of the full LOTIS-7 trial, compendia inclusion and regulatory strategy and the commercial opportunity; the timing of the PFS events and topline data release for LOTIS-5 and the results of the trial, the timing for the sBLA submission and full FDA approval; the Company's ability

More news about: ADC Therapeutics SA


Jan 30, 2026, 12:18 ET Hot Chili Quarterly Report - Period Ending 31 December 2025

and exclusions. The PFS Technical Report is intended to be read as a whole, and sections should not be read or relied upon out of context. The technical information in this report is subject to the assumptions and qualifications to be contained in the PFS Technical Report. The PFS Technical Report replaces

More news about: Hot Chili Limited


Jan 30, 2026, 10:36 ET $170B Patent Cliff Ignites Biotech Deal Wave: Late-Stage Platforms Command Premium

duration of response, though overall survival did not reach statistical significance.EPCORE DLBCL-1 is the first Phase 3 study to demonstrate PFS improvement in patients with relapsed/refractory DLBCL treated with a CD3xCD20 T-cell engaging bispecific monotherapy. AbbVie and Genmab

More news about: Equity Insider


Jan 29, 2026, 06:30 ET Hemlo Mining Corp. Initiates 130,000 Metre Exploration Drilling Program for 2026

Company released a technical report disclosing the results of a Pre-Feasibility Study (the "PFS") on the Mine, which demonstrated significant leverage to gold price assumptions (see table 1). As disclosed in the PFS, increases in the assumed gold price result in materially higher Net Present Value using

More news about: Hemlo Mining Corp.


Jan 27, 2026, 15:49 ET DARZALEX FASPRO®-based quadruplet regimen approved in the U.S. for newly diagnosed patients with multiple myeloma who are transplant ineligible

Secondary endpoints include complete response or better rate, progression-free survival (PFS), sustained MRD-negativity rate, MRD-negative rate at 1-year, overall response rate, time to and duration of response, PFS on next line of therapy, overall survival and safety. The trial enrolled 395 patients in

More news about: Johnson & Johnson


Jan 22, 2026, 07:00 ET Mayfair Gold to Commence Trading on the NYSE American Under the Ticker "MINE" on January 27, 2026

is a Canadian gold development stage company focused on advancing the 100% controlled Fenn-Gib Project in the Timmins region of Northern Ontario. The PFS outlines the potential to develop Fenn-Gib into a new Canadian gold producer for initial development capital of C$450 million, with a base case payback

More news about: Mayfair Gold Corp.


Jan 22, 2026, 05:00 ET New Breast Cancer Therapy to Reduce Risk of Recurrence and Improve Disease-Free Survival Now Available in Thailand

primary outcome measures for the trial were progression-free survival (PFS), and overall survival (OS). Median PFS was 5.6 months for patients who received N+C and 5.5 months for those receiving L+C (hazard ratio = 0.76, p = 0.0059). The PFS rate at 12 months was 29% versus 15%, respectively. Median OS was

More news about: Specialised Therapeutics


Jan 21, 2026, 10:00 ET What's the Difference Between Criminal Threat and Harassment? | Wichita Criminal Threat Defense Lawyer

FinesPossible jail timeCourt-ordered counselingProtection-from-abuse (PFA) or protection-from-stalking (PFS) ordersOngoing impacts on reputation and employmentWhat's the Difference?While criminal threat and harassment can

More news about: McConnell Law Firm


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.